Parry, Christopher M ORCID: 0000-0002-0256-1325, Chan, Li F, Carr, Daniel F and Hawcutt, Daniel B ORCID: 0000-0002-8120-6507
(2023)
Platelet-derived growth factor D expression in adrenal cells is modulated by corticosteroids: putative role in adrenal suppression.
PEDIATRIC RESEARCH, 93 (1).
pp. 97-101.
Text
H295R manuscript_9_Nature specs_041021.docx - Author Accepted Manuscript Download (92kB) |
|
Text
s41390-022-02094-9.pdf - Published version Download (785kB) | Preview |
Abstract
<h4>Background</h4>Adrenal suppression is a clinically concerning side effect of inhaled corticosteroid (ICS) treatment in patients with asthma. Increased susceptibility to ICS-induced adrenal suppression has previously been identified in those with the rs591118 polymorphism in platelet-derived growth factor D (PDGFD). The mechanism underpinning this relationship is not known.<h4>Methods</h4>H295R cells were genotyped for rs591118 using a validated Taqman PCR allelic discrimination assay. H295R cell viability was determined after treatment with beclometasone and fluticasone (range 0-330 μM). Cortisol was measured in cell culture medium using competitive enzyme immunoassay.<h4>Results</h4>PDGFD protein expression in H295R cells was confirmed using Western blotting. When ACTH and forskolin were added to H295R cells, a reduction in PDGFD expression was seen, which was then restored by incubation with prochloraz, a known inhibitor of steroidogenesis. A dose-dependent, decrease in PDGFD expression was observed with beclometasone (over a 24 h incubation period) but not with beclometasone incubations beyond 24 h nor with fluticasone (at 24 or 48 h).<h4>Conclusions</h4>H295R cells express PDGFD protein, which can be modulated by incubation with steroidogenesis agonists and antagonists and additionally with exogenous beclometasone.<h4>Impact</h4>PDGFD is expressed in the human adrenal cell line, H295R, and expression can be modulated by beclometasone as well as agonists/antagonists of steroidogenesis. This builds on previous research that identified a SNP in PDGFD (rs591118) as an independent risk factor for adrenal suppression in adults and children with obstructive airway disease treated with inhaled corticosteroids. First in vitro experiments to support a link between the PDGF and cortisol production pathways, supporting the hypothesis that PDGFD variants can affect an individual's sensitivity to corticosteroid-induced adrenal suppression.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | Humans, Beclomethasone, Hydrocortisone, Adrenal Cortex Hormones, Platelet-Derived Growth Factor, Adult, Child, Fluticasone |
Divisions: | Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Clinical Directorate Faculty of Health and Life Sciences > Institute of Life Courses and Medical Sciences |
Depositing User: | Symplectic Admin |
Date Deposited: | 19 May 2022 14:20 |
Last Modified: | 23 Feb 2023 05:19 |
DOI: | 10.1038/s41390-022-02094-9 |
Related URLs: | |
URI: | https://livrepository.liverpool.ac.uk/id/eprint/3155157 |